A bill to legalize medical marijuana on Tuesday won the approval of New Zealand’s parliamentarians on its third and final vote, paving the way for companies to manufacture MMJ products for domestic and international markets.
Matt Lamers
Matt Lamers's Latest Posts
Cannabis shortages plague Canadian retailers; here’s how they’re responding
As the Canadian cannabis industry struggles to provide enough supply to meet exuberant demand since recreational use became legal, private retailers are faced with their own challenge: how to stay in business.
Canopy Growth boosts M&A transparency in wake of Aphria fiasco
Cash-rich Canopy Growth bought global vaporizer leader Storz & Bickel for 220 million Canadian dollars ($160 million) in a bid to improve its portfolio of intellectual property. The all-cash deal is also intended to position Canopy to capitalize on the next wave...
Marlboro maker, Cronos join forces in exclusive CA$2.4 billion deal to tap global cannabis opportunities
Altria Group, one of the largest tobacco companies in North America, has agreed to invest 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group – the most significant foray by Big Tobacco into the rapidly growing cannabis industry to date.
Altria also agreed to make Cronos its exclusive partner for international cannabis opportunities.
Regulator warns Canadian marijuana firms against ‘problematic practices’
Canada’s stock market regulator warned publicly traded companies in emerging industries such as cannabis and fintech against “problematic promotional activities” that could artificially increase share prices and put investors at risk. The warning from the Canadian...
Medical cannabis export law passes first vote in Israeli Parliament
A long-awaited bill to permit the export of medical cannabis from Israel passed the first of three crucial votes in the country’s Parliament, potentially setting it up for approval in the first half of 2019, according to experts. The bill was passed in the first...
Aphria warned by Health Canada about ‘noncompliance’ in June
Beleaguered Canadian cannabis giant Aphria was given a noncompliance rating and issued a warning letter by Health Canada in June over “critical” findings discovered in a routine annual inspection.
Cannabis firm Cronos confirms talks for investment by Marlboro maker Altria
Cronos Group – the Ontario, Canada-based cannabis multinational – confirmed it is engaged in discussions with tobacco giant Altria Group about a “potential investment” by the company that produces Marlboro cigarettes.
‘It’s a game changer’: Ontario company prepares Canada’s first outdoor cannabis crop
Ontario-based 48North is laying the groundwork for what would be Canada’s first large-scale outdoor marijuana crop under the Cannabis Act this spring, pending required permits from Health Canada. “With Health Canada’s permission and approval, we’ll be doing a very...
‘Christmas is coming early’: Canada’s draft rules for marijuana edibles expected in coming weeks
Hotly anticipated draft regulations to allow legal sales of cannabis edibles and concentrates in Canada are expected to be released before Christmas, according to sources, paving the way for a new wave of businesses and entrepreneurs aiming to capitalize on the...
Draft medical marijuana law in Thailand breezes through key hurdle
A draft bill to legalize medical cannabis in Thailand breezed through a key hurdle in the National Legislative Assembly when 145 lawmakers voted to advance the proposed law.
Turmoil at Canadian marijuana producer after license revoked
The senior leadership of a British Columbia marijuana company abruptly resigned after Health Canada said it planned to revoke the production and dealer licenses of its subsidiary over “unauthorized activities with cannabis.” Ascent Industries announced the departure...
